|Bid||0.0000 x 2200|
|Ask||0.0000 x 4000|
|Day's Range||3.9000 - 4.0200|
|52 Week Range||2.8200 - 5.2400|
|Beta (5Y Monthly)||2.22|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 09, 2021 - Aug 13, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Dec 18, 2012|
|1y Target Est||9.80|
Investors need to pay close attention to for Spectrum Pharmaceuticals (SPPI) stock based on the movements in the options market lately.
Spectrum Pharmaceuticals today presented an e-poster on poziotinib CNS activity in patients with NSCLC EGFR or HER2 exon 20 mutations at ASCO.
Spectrum Pharmaceuticals announces that the FDA is "on site" for the ROLONTIS® (eflapegrastim) manufacturing facility inspection.